Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OR51E2 | Q9H255 | 1/20 | 0.40 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.38 |
| ▸ | LMNA | P02545 | 2/20 | 0.36 |
| ▸ | USP2 | O75604 | 1/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | NAAA | Q02083 | 1/20 | 0.35 |
| ▸ | ESR1 | P03372 | 1/20 | 0.35 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.35 |
| ▸ | KDR | P35968 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL115794 | 0.86 | ALDH1A1 (0.52) | HCAR2ALDH1A1LMNAKDM4EDUSP3 | |
| SCHEMBL114065 | 0.85 | NAAA (0.55) | ALDH1A1LMNAUSP2KDM4EDUSP3 | |
| SCHEMBL28988208 | 0.84 | KDM4E (0.53) | LMNAUSP2KDM4EDUSP3MEN1 | |
| SCHEMBL1455849 | 0.83 | HCAR2 (0.40) | HCAR2ALDH1A1LMNANAAATSHR | |
| SCHEMBL28388810 | 0.83 | HCAR2 (0.40) | HCAR2ALDH1A1LMNANAAATSHR | |
| SCHEMBL9636511 | 0.83 | HCAR2 (0.40) | HCAR2ALDH1A1LMNANAAATSHR | |
| SCHEMBL23467113 | 0.83 | NAAA (0.59) | LMNAUSP2KDM4EDUSP3MEN1 | |
| SCHEMBL114472 | 0.83 | NAAA (0.59) | LMNAUSP2KDM4EDUSP3MEN1 | |
| SCHEMBL117824 | 0.83 | NAAA (0.59) | LMNAUSP2KDM4EDUSP3MEN1 | |
| SCHEMBL115554 | 0.83 | NAAA (0.59) | LMNAUSP2KDM4EDUSP3MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 51 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2013106249-A1 | METHOD OF BIOBASED CHEMICAL PRODUCTION FROM CRUDE BIOGLYCERIN | Vertichem Corporation (CA) | 2013-07-18 | — | — | WO | claimed |
| US-20130096322-A1 | METHOD OF BIOBASED CHEMICAL PRODUCTION FROM CRUDE BIOGLYCERIN OF RECYCLED OIL, GREASE, AND FAT ORIGIN | THESIS CHEMISTRY, LLC (US) | 2013-04-18 | — | — | US | claimed |
| US-20130091759-A1 | METHOD OF BIOBASED CHEMICAL PRODUCTION FROM CRUDE BIOGLYCERIN OF PLANT ORIGIN | THESIS CHEMISTRY, LLC (US) | 2013-04-18 | — | — | US | claimed |
| US-20130091760-A1 | METHOD OF BIOBASED CHEMICAL PRODUCTION FROM CRUDE BIOGLYCERIN OF ANIMAL ORIGIN | THESIS CHEMISTRY, LLC (US) | 2013-04-18 | — | — | US | claimed |
| EP-0066107-B1 | 2-HYDROXY-3-METHYL-BRANCHED-ALKOXYPROPYL GLYCERYL ETHER AND COSMETIC COMPOSITION CONTAINING SAME | Kao Corporation (JP) | 1985-08-14 | — | — | EP | claimed |
| US-20250333686-A1 | RECOMBINANT HOST CELLS AND METHODS FOR THE PRODUCTION OF GLYCERIC ACID AND DOWNSTREAM PRODUCTS | LYGOS, INC. (US) | 2025-10-30 | — | — | US | disclosed |
| WO-2025132660-A1 | METHOD FOR TREATING HUMAN PERSPIRATION, AND ASSOCIATED COMPOSITION | L'OREAL (FR) | 2025-06-26 | — | — | WO | disclosed |
| US-20250009621-A1 | ANHYDROUS HAIR TREATMENT COMPOSITION COMPRISING ALPHA HYDROXY ACID ESTER | L'OREAL (FR) | 2025-01-09 | — | — | US | disclosed |
| US-12188008-B2 | Recombinant host cells and methods for the production of glyceric acid and downstream products | LYGOS, INC. (US) | 2025-01-07 | — | — | US | disclosed |
| WO-2025006991-A1 | ANHYDROUS HAIR TREATMENT COMPOSITION COMPRISING ALPHA HYDROXY ACID ESTER | L'OREAL (FR) | 2025-01-02 | — | — | WO | disclosed |
| WO-2023182149-A1 | METHOD FOR THICKENING OILY COMPONENT AND COMPOSITION CONTAINING OILY COMPONENT | 株式会社ADEKA | 2023-09-28 | — | — | WO | disclosed |
| CN-116749348-A | Concrete mixing plant CO 2 System and method for sealing and utilizing | 湖北工业大学 | 2023-09-15 | — | — | CN | disclosed |
| US-20020068075-A1 | Citral Acetal | KAO CORPORATION (JP) | 2002-06-06 | — | — | US | disclosed |
| EP-1094821-A4 | PREPARATION AND USE OF SULFUR-CONTAINING PHOSPHONOFORMATE DERIVATIVES AND ANALOGS | UNIV SOUTHERN CALIFORNIA (US) | 2002-04-10 | — | — | EP | disclosed |
| EP-1094821-A1 | PREPARATION AND USE OF SULFUR-CONTAINING PHOSPHONOFORMATE DERIVATIVES AND ANALOGS | THE UNIVERSITY OF SOUTHERN CALIFORNIA (US) | 2001-05-02 | — | — | EP | disclosed |
| EP-0831767-A4 | ALPHA HYDROXYACID ESTERS FOR SKIN AGING | YU RUEY J (US) | 2000-05-17 | — | — | EP | disclosed |
| WO-2000002566-A1 | PREPARATION AND USE OF SULFUR-CONTAINING PHOSPHONOFORMATE DERIVATIVES AND ANALOGS | THE UNIVERSITY OF SOUTHERN CALIFORNIA (US) | 2000-01-20 | — | — | WO | disclosed |
| EP-0831767-A1 | ALPHA HYDROXYACID ESTERS FOR SKIN AGING | Yu, Ruey J., Dr. (US) | 1998-04-01 | — | — | EP | disclosed |
| US-5686489-A | TOPICALLY APPLIED TO INDUCE GLYCOSAMINOGLYCAN, PROTEOGLYCAN, COLLAGEN AND ELASTIN BIOSYNTHESIS; WRINKLE RESISTANCE | TRISTRATA TECHNOLOGY, INC. (US) | 1997-11-11 | — | — | US | disclosed |
| WO-1996040047-A1 | ALPHA HYDROXYACID ESTERS FOR SKIN AGING | YU RUEY J (US) | 1996-12-19 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250009621-A1 | ANHYDROUS HAIR TREATMENT COMPOSITION COMPRISING ALPHA HYDROXY ACID ESTER | EBP, ADH1A, ADH1C | OR51E2 2410/4885HCAR2 165/4885ALDH1A1 119/4885 |
| US-20020068075-A1 | Citral Acetal | LDHA, LDHB, ALDH1A1 | OR51E2 1706/4885HCAR2 311/4885ALDH1A1 3/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.